RecruitingNCT07794618
3,593
studies recruiting now
as of 7 Sept 2026
30,655
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
4 Sept 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07805616
Prognostic Value of 2026 AHA/ACC Clinical Categorization in Acute Pulmonary Embolism Patients Presenting to the Emergency Department
RecruitingPhase 1NCT06191978
A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
RecruitingPhase 1NCT06846606
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
RecruitingNot applicableNCT06819462
Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain Injury
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 3,593 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Acute graft versus host disease study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Acute graft versus host disease
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
8 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Methotrexate (Ebetrex)
Phase 3Etanercept (Benepali)
Phase 2Aldesleukin (Proleukin)
Phase 1/2Pentostatin (Nipent)
Phase 1/2Ruxolitinib (Jakavi)
Phase 1/2Tocilizumab (Actemra roactemra)
Phase 1Flizasertib
Phase 1Neihulizumab
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).